An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2
NCT02756832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1409
Last updated 2019-07-10
Summary
The purpose of this study is to evaluate the effect of alogliptin benzoate (VIPIDIA®) on glycosylated hemoglobin (HbA1c) level dynamics in participants with diabetes mellitus type 2 (T2DM) at Month 6.
Conditions
Interventions
- DRUG
-
Alogliptin Benzoate
Alogliptin benzoate tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director Clinical Science · Takeda
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-20
- Primary Completion
- 2018-04-28
- Completion
- 2018-04-28
- FDA Drug
- Yes
Countries
- Russia
Study Locations
More Related Trials
-
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
NCT00707993 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes
NCT00351832 ·Status: COMPLETED ·Phase: PHASE3
-
Metformin Versus Vildagliptin for Diabetic Hypertensive Patients
NCT03253562 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
NCT01235819 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
NCT01652729 ·Status: COMPLETED ·Phase: PHASE3
-
Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus
NCT03829891 ·Status: COMPLETED ·Phase: NA
-
A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
NCT00300287 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
NCT00716092 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
NCT06145360 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes
NCT00838916 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)
NCT01541956 ·Status: COMPLETED ·Phase: PHASE4
-
Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
NCT00138593 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
NCT02719756 ·Status: UNKNOWN ·Phase: PHASE4
-
Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
NCT01766778 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia
NCT00101712 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
NCT00819091 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus
NCT01642108 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
NCT02853630 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus
NCT04014192 ·Status: UNKNOWN ·Phase: PHASE4
-
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
NCT00102466 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
NCT00396227 ·Status: COMPLETED ·Phase: PHASE3
-
Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
NCT00237237 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
NCT00260156 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
NCT01339143 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
NCT00728351 ·Status: COMPLETED ·Phase: PHASE3